Results 21 to 30 of about 11,661 (217)
Respiratory Medicine Case Reports, 2017 Mycobacterium abscessus, which is ubiquitous environmental organism, is more likely to cause pulmonary infection in the presence underlying lung disease and immunosuppression.
Celestine Ishiekwene +5 more
doaj +2 more sources
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. [PDF]
PLoS ONE, 2015 PurposeClarithromycin was considered the cornerstone for the treatment of Mycobacterium abscessus complex infections. Genetic resistance mechanisms have been described and many experts propose amikacin as an alternative.
Marc Rubio +5 more
doaj +2 more sources
Trends in Microbiology, 2021 No abstract ...
Boudehen, Yves-Marie, Kremer, Laurent
openaire +3 more sources
Highly resistant Mycobacterium abscessus subsp. abscessus infection in a Swiss cat [PDF]
, 2021 A 2-year-old European shorthair cat was presented with a nonhealing skin lesion on the right abdominal wall. Repeated surgical excision and antimicrobial treatment with cefovecin, clindamycin, and trimethoprim-sulfamethoxazole did not lead to clinical ...
Giovanni Ghielmetti +10 more
core +1 more source
Treatment of Mycobacterium abscessus Complex [PDF]
Seminars in Respiratory and Critical Care Medicine, 2018 AbstractOf the nontuberculous mycobacteria (NTMs) causing lung disease, members of the Mycobacterium abscessus complex (MABc) present a formidable obstacle to successful management. This challenge starts from a poorly understood pathogenesis, continues with complicated subspecies variation in treatment response, and extends to the multidrug-resistant ...
Luke, Strnad, Kevin L, Winthrop
openaire +2 more sources
Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity
Frontiers in Microbiology, 2022 Therapeutic options for treating Mycobacterium abscessus infections are extremely limited; quinolones are important. The in vitro anti-M. abscessus activities of nine quinolones, emphasizing sitafloxacin, were investigated.
Siyuan He +12 more
doaj +1 more source
Mycobacterium abscessus peritonitis and ventriculitis associated with ventriculoperitoneal shunt
IDCases, 2022 Mycobacterium abscessus, like most nontuberculous mycobacteria, is a pervasive organism. It frequently presents as a healthcare-associated infection. Mycobacterium abscessus infections are notoriously difficult to treat, requiring multidrug regimens and ...
D. Clabots, A. Serrat
doaj +1 more source
Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus
Microbiology, 2023 Bacteria use population heterogeneity, the presence of more than one phenotypic variant in a clonal population, to endure diverse environmental challenges – a ‘bet-hedging’ strategy. Phenotypic variants have been described in many bacteria, but the phenomenon is not well-understood in mycobacteria, including the environmental factors that influence ...
Sarah E. M. Born +5 more
openaire +2 more sources
Mycobacterium abscessus Ventriculoperitoneal Shunt Infection [PDF]
Cureus, 2021 Mycobacterium abscessus is a rapidly growing mycobacterium (RGM) known to be abundant in soil, dust and water. Unlike other non-tuberculous mycobacteria, RGM is typically resistant to first-line anti-tuberculosis drugs. These organisms are known to cause community and hospital-acquired infections; however, central nervous system (CNS) infections caused
Herrera, Danay +6 more
openaire +2 more sources
MabsBase: A Mycobacterium abscessus Genome and Annotation Database [PDF]
, 2013 Mycobacterium abscessus is a rapidly growing non-tuberculous mycobacterial species that has been associated with a wide spectrum of human infections. As the classification and biology of this organism is still not well understood, comparative genomic ...
Lokanathan, N. +20 more
core +1 more source